A History of Depression and Gastrointestinal Symptoms May Predict Risk for Subsequent IBD
Investigators assessed whether depression, adjusted for preexisting gastrointestinal symptoms, is associated with subsequent inflammatory bowel disease.
Investigators assessed whether depression, adjusted for preexisting gastrointestinal symptoms, is associated with subsequent inflammatory bowel disease.
While the global pandemic is obviously stressful for everyone, the impact of factors related to the family unit and other protective psychosocial factors that could produce resilient or psychopathological results in college students has not been sufficiently assessed nor differentiated by gender.
Researchers compared the rate at which patients diagnosed with both depression and a substance use disorder received acute and continuous pharmacotherapy and psychotherapy with the rate at which patients solely diagnosed with depression received the same treatments.
Among individuals with treatment-resistant depression (TRD), the dissociative side effect of “floating” is not related to an antidepressant response to ketamine and thus cannot be utilized as a predictor of treatment response.
Testing for genetic variants may allow clinicians to predict how patients with major depressive disorder metabolize antidepressants.
Depression and anxiety exhibited in COVID-19 patients may be a sign that the virus impacts the central nervous system, as these symptoms are closely associated with a loss of smell and taste rather than more severe manifestations of the virus.
A team of investigators assessed the impact of anxiety and mood disorders on treatment with anti-tumor necrosis factor agents in individuals with inflammatory bowel disease.
While the relationship between current mood state and cognitive impairment is unclear, more severe depression has been linked to greater impairment.
Psychosis and BPD have previously been linked to persistent nightmares in childhood, and these findings highlight the importance of confronting sleep disturbances at young ages.
Pre/probiotic therapy may be useful for patients with depression and/or anxiety disorders.